克冠(艹卓)是一种新的冠状动脉扩张剂。国内于1975年研制成功,曾在北京等地的九个医院临床试用,治疗冠心病的疗效相当或超过硝酸异山梨醇脂、心脉宁、毛冬青、丹参和川芎注射液等。国外的资料也说明它是一个有效的药物。对克冠草药理作用的研究,国外曾有一些报告,但国内的研究工作尚少。克冠(艹卓)对血小板聚集的影响,国内尚未见报告。为给国 Crown (艹 Zhuo) is a new coronary dilating agent. It was successfully developed in China in 1975 and has been used in clinical trials in nine hospitals in Beijing and other places. The efficacy of treating coronary heart disease is equivalent to or more than that of isosorbide dinitrate, Xinmaining, Mao Dongqing, Danshen and Chuanxiong Injection. Foreign information also shows that it is an effective drug. Studies on the pharmacological effects of Kusakusa herb have some reports abroad, but there are still few studies in China. Crown (Zhuo Zhuo) on the impact of platelet aggregation, has not been reported in China. For the country